Radiant Innovation

Radiant Innovation Equity Turnover

The Equity Turnover of Radiant Innovation (3373.TWO) as of Oct 22, 2026 is 0.49. In the previous year, Equity Turnover was 0.49 — a change of 0.53% (higher).

Equity Turnover

0.49

YoY

0.53%

Last updated:

Equity Turnover of Radiant Innovation is 2025 0.49 . Equity Turnover of Radiant Innovation was 2024 0.49 . It decreases by 0.53% higher compared to the previous year.

The Radiant Innovation Equity Turnover history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Turnover
Date
Equity Turnover
Jan 1, 2018
1.22 TWD
Jan 1, 2019
1.19 TWD
Jan 1, 2020
1.94 TWD
Jan 1, 2021
0.92 TWD
Jan 1, 2022
0.55 TWD
Jan 1, 2023
0.45 TWD
Jan 1, 2024
0.49 TWD
Jan 1, 2025
0.49 TWD
The Radiant Innovation Equity Turnover history
YEAREquity TurnoverYoY
0.49+0.53%
0.49+7.47%
0.45-18.23%
0.55-40.09%
0.92-52.52%
1.94+63.07%
1.19-2.64%
1.22+6.30%
1.15-4.62%
1.21-2.46%
1.24+18.45%
1.04—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Radiant Innovation Stock analysis

What does Radiant Innovation do? Radiant Innovation Inc. generates revenue through the design, manufacture, and sale of infrared technology products. The company's main products include infrared temperature measurement instruments, ear temperature guns, frontal temperature guns, and other body temperature measurement products, alongside carbon dioxide detectors, infrared thermal imagers, and blood glucose dedicated chipsets. These products are distributed domestically and internationally across Asia, the Americas, Europe, and other regions. The primary buyers are healthcare providers, medical facilities, and electronic component distributors who require precise measurement tools and specialized components for health monitoring and diagnostics. The firm's product portfolio targets healthcare and industrial segments, with infrared thermal imagers used in building inspections and carbon dioxide detectors deployed in environmental monitoring. Blood glucose dedicated chipsets are supplied to medical device manufacturers for integration into diagnostic equipment. International distribution channels focus on regions like Asia, the Americas, and Europe, where demand for health-related measurement devices remains strong. Revenue streams are driven by direct sales to medical institutions, electronic component distributors, and industrial clients. The company's product lines serve both consumer-facing health monitoring applications and specialized industrial uses, with a strong emphasis on accuracy and reliability in temperature and gas detection technologies. Radiant Innovation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Radiant Innovation stock

Equity Turnover of Radiant Innovation is 0.49 in 2025.

Equity Turnover of Radiant Innovation changed from 0.49 to 0.49, representing a 0.53% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Equity Turnover Radiant Innovation since 2006 – with annual values, charts, and detailed analysis.

Equity turnover measures how efficiently a company uses shareholders' equity to generate revenue. It is a component of the DuPont analysis framework.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Turnover's Radiant Innovation with sector peers and the industry average to assess whether it is attractive.

To evaluate Equity Turnover's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Equity Turnover.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Radiant Innovation

All Key Metrics — Radiant Innovation